Scholarly Presentations

“Advancing Cancer Therapy: Collaborative Development of MLKL Modulators to Target Necroptosis.” Gulf Coast Consortia - Schrödinger Research Event, Houston, TX, 2024 (Oral presentation)

“Expanded SAR Analysis of 3,5-Diphenyl-2-Aminopyridines as Receptor Interacting Protein Kinase 2 and Nucleotide Oligomerization Domain Cell Signaling Inhibitor.” Gordon Research Seminar/Conference (GRS/GRC), New London, NH, 2023 (Poster)

“Expanded SAR Analysis of 3,5-Diphenyl-2-Aminopyridines as Receptor Interacting Protein Kinase 2 and Nucleotide Oligomerization Domain Cell Signaling Inhibitor.” ACS Meeting, San Francisco, CA, 2023 (Poster)

“Developing Activators for Mixed Lineage Kinase Domain-Like (MLKL) as Terminal Effector of Necroptosis.” MALTO Conference, Houston, TX, 2023 (Oral presentation)